Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma - Croucher, P; Shipman, C; Perry, M; Lippitt, J; Asosingh, K; van Beek, E; Van Camp, B; Russell, R; Dunstan, C; Vanderkerken, K (2001)